Medical AI service valued at $15B: about 65% of US doctors use it

OpenEvidence closed a $250M Series D at a $15B valuation, 25% above its January valuation of $12B. According to the company, about 65% of US doctors use the service, and in August 2026 it hosted 42 million clinical consultations a month.